CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RHHBY

Phase 3

Development Phase

3

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q2 '27
RHHBYPhase 3

Ranibizumab Phase 3 Est. Readout

Ranibizumab
Q2 2027~Q
CT.gov
00%
Q1 '27
RHHBYPhase 2

Ranibizumab Phase 2 Est. Readout

Ranibizumab
Q1 2027~Q
CT.gov
00%
Feb '27
RHHBYPhase 3

Ranibizumab Phase 3 Est. Readout

Ranibizumab
Feb 2027~
CT.gov
00%
Competitive Landscape
Drug Information

Target Indication

Diabetic Macular Edema

Clinical Trial

NCT02699450

Last updated: 1/14/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.